UK markets close in 6 hours 41 minutes

Abiomed, Inc. (0H7S.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
377.39-0.11 (-0.03%)
As of 06:05PM GMT. Market open.
Full screen
Previous close377.50
Bid0.00 x 0
Ask0.00 x 0
Day's range0.00 - 0.00
52-week range
Avg. volumeN/A
Market cap167.7M
Beta (5Y monthly)1.28
PE ratio (TTM)1.27
EPS (TTM)2.98
Earnings date01 Feb 2023 - 06 Feb 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Here's Why You Should Hold on to Abiomed (ABMD) Stock Now

    Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.

  • Motley Fool

    Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed

    Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently made headlines by announcing it will acquire medical device company Abiomed for $16.6 billion in an all-cash transaction. The buyout offer was roughly a 50% premium to where shares of Abiomed traded at the time of the announcement, signaling Johnson & Johnson's desire to make the deal happen. Few companies have the financial firepower Johnson & Johnson has, so I'll break down the acquisition's financial impact and whether Abiomed will make its new parent company a better investment for long-term investors.

  • Motley Fool

    Johnson & Johnson's Big Purchase, Amazon's New Moves, and More

    Why he believes Abiomed is worth a "shock and awe" price. How Abiomed will strengthen Johnson & Johnson's medical device portfolio. Also, Motley Fool host Alison Southwick and Motley Fool personal finance expert Robert Brokamp discuss how shortcuts can make you a smarter saver.